Elanco Animal Health (ELAN) Research & Development (2017 - 2026)

Elanco Animal Health has disclosed Research & Development across 10 years of filings, most recently posting $92.0 million for Q2 2026.

• In Q2 2026, Research & Development changed 0.0% year-over-year to $92.0 million; the TTM figure through Jun 2026 stood at $371.0 million (up 4.8% YoY), while the FY2025 annual figure was $368.0 million, up 6.98% from the prior year.
• Research & Development came in at $92.0 million for Q2 2026 at Elanco Animal Health, down from $97.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $97.0 million in Q1 2026 to a low of $78.0 million in Q3 2022.
• Average Research & Development over 5 years is $86.1 million, with a median of $86.5 million recorded in 2023.
• Year-over-year, Research & Development slipped 17.02% in 2022 and climbed 14.81% in 2025.
• Over 5 years, Research & Development stood at $80.0 million in 2022, then dropped by 1.25% to $79.0 million in 2023, then increased by 2.53% to $81.0 million in 2024, then rose by 14.81% to $93.0 million in 2025, then decreased by 1.08% to $92.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $92.0 million in Q2 2026, $97.0 million in Q1 2026, and $93.0 million in Q4 2025.